Schellekens H - Search Results

1

Bioequivalence and the immunogenicity of biopharmaceuticals.

Schellekens H. Schellekens H. Nat Rev Drug Discov. 2002 Jun;1(6):457-62. doi: 10.1038/nrd818. Nat Rev Drug Discov. 2002. PMID: 12119747 Review.

2

Immunogenicity of biopharmaceuticals.

Kessler M, Goldsmith D, Schellekens H. Kessler M, et al. Among authors: schellekens h. Nephrol Dial Transplant. 2006 Oct;21 Suppl 5:v9-12. doi: 10.1093/ndt/gfl476. Nephrol Dial Transplant. 2006. PMID: 16959792 Review.

3

Follow-on biologics: challenges of the "next generation".

Schellekens H. Schellekens H. Nephrol Dial Transplant. 2005 May;20 Suppl 4:iv31-36. doi: 10.1093/ndt/gfh1085. Nephrol Dial Transplant. 2005. PMID: 15827057 Review.

4

Factors influencing the immunogenicity of therapeutic proteins.

Schellekens H. Schellekens H. Nephrol Dial Transplant. 2005 Jun;20 Suppl 6:vi3-9. doi: 10.1093/ndt/gfh1092. Nephrol Dial Transplant. 2005. PMID: 15958824 Review.

5

Immunogenicity of recombinant human proteins: causes and consequences.

Schellekens H, Casadevall N. Schellekens H, et al. J Neurol. 2004 Jun;251 Suppl 2:II4-9. doi: 10.1007/s00415-004-1202-9. J Neurol. 2004. PMID: 15264106 Review.

6

Structure-immunogenicity relationships of therapeutic proteins.

Hermeling S, Crommelin DJ, Schellekens H, Jiskoot W. Hermeling S, et al. Among authors: schellekens h. Pharm Res. 2004 Jun;21(6):897-903. doi: 10.1023/b:pham.0000029275.41323.a6. Pharm Res. 2004. PMID: 15212151 Review.

7

Immunogenicity of therapeutic proteins.

Schellekens H. Schellekens H. Nephrol Dial Transplant. 2003 Jul;18(7):1257-9. doi: 10.1093/ndt/gfg164. Nephrol Dial Transplant. 2003. PMID: 12808158 Review. No abstract available.

8

Immunogenicity of therapeutic proteins: clinical implications and future prospects.

Schellekens H. Schellekens H. Clin Ther. 2002 Nov;24(11):1720-40; discussion 1719. doi: 10.1016/s0149-2918(02)80075-3. Clin Ther. 2002. PMID: 12501870 Review.

9

'Biogenerics': the off-patent biotech products.

Schellekens H, Ryff JC. Schellekens H, et al. Trends Pharmacol Sci. 2002 Mar;23(3):119-21. doi: 10.1016/S0165-6147(00)01967-2. Trends Pharmacol Sci. 2002. PMID: 11879678 Review.

10

Immunogenicity of rDNA-derived pharmaceuticals.

Ryff JC, Schellekens H. Ryff JC, et al. Among authors: schellekens h. Trends Pharmacol Sci. 2002 Jun;23(6):254-6. doi: 10.1016/s0165-6147(02)02024-2. Trends Pharmacol Sci. 2002. PMID: 12084625 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results